Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli L...

FDA Recall #D-0884-2022 — Class II — April 5, 2022

Recall #D-0884-2022 Date: April 5, 2022 Classification: Class II Status: Completed

Product Description

Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80

Reason for Recall

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions

Recalling Firm

Cardinal Health Inc. — Dublin, OH

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

1 box

Distribution

NM only

Code Information

Lot #: D484557A, Exp: 10/25/2023.

Status

Completed

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls